Cite
HARVARD Citation
Choi, J. et al. (2020). Pathological outcomes of HER2‐positive non‐metastatic breast cancer patients treated with neoadjuvant dual anti‐HER2 therapy and taxane: An Australian experience. Asia-Pacific journal of clinical oncology. 16 (3), pp. 103-107. [Online].